Cinchonine: Difference between revisions
Appearance
Content deleted Content added
m Typo in chembox |
m Open access bot: pmc updated in citation with #oabot. |
||
(36 intermediate revisions by 30 users not shown) | |||
Line 1: | Line 1: | ||
{{More citations needed|date=January 2021}} |
|||
{{chembox |
{{chembox |
||
| Watchedfields = changed |
|||
| verifiedrevid = 420135264 |
| verifiedrevid = 420135264 |
||
| |
| Name = Cinchonine |
||
| |
| ImageFile = Cinchonine.svg |
||
| ImageName = Cinchonine |
| ImageSize = 180 |
||
| ImageName = Cinchonine |
|||
| IUPACName = (9''S'')-Cinchonan-9-ol<ref>{{cite web |title=Common Chemistry - Substance Details - 118-10-5 : Cinchonan-9-ol, (9S)- |url=https://commonchemistry.org/ChemicalDetail.aspx?ref=118-10-5 |website=commonchemistry.org |accessdate=22 May 2020}}</ref><ref>{{BlueBook2013|rec=(Appendix 3, p. 1517)}}</ref> |
|||
| IUPACName = Cinchonine |
|||
| SystematicName = (''S'')-[(2''R'',4''S'',5''R'')-5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol |
|||
| Section1 = {{Chembox Identifiers |
| Section1 = {{Chembox Identifiers |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 746392 |
| ChemSpiderID = 746392 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
| PubChem = 90454 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = V43X79NZCD |
| UNII = V43X79NZCD |
||
| InChI = 1/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18-,19-/m0/s1 |
| InChI = 1/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18-,19-/m0/s1 |
||
| InChIKey = KMPWYEUPVWOPIM-LSOMNZGLBY |
| InChIKey = KMPWYEUPVWOPIM-LSOMNZGLBY |
||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 496893 |
| ChEMBL = 496893 |
||
| EC_number = 204-234-6 |
|||
⚫ | |||
| ChEBI = 27509 |
|||
⚫ | |||
| Beilstein = 89689 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
|||
| Section2 = {{Chembox Properties |
| Section2 = {{Chembox Properties |
||
| Formula = C<sub>19</sub>H<sub>22</sub>N<sub>2</sub>O |
|||
| MolarMass = 294.39 g/mol |
|||
| Density = |
|||
| MeltingPt = 260-263 |
|||
| BoilingPt = |
|||
}} |
}} |
||
| Section7 = {{Chembox Hazards |
|||
| GHSPictograms = {{GHS07}} |
|||
| GHSSignalWord = Warning |
|||
| HPhrases = {{H-phrases|302|317|332}} |
|||
| PPhrases = {{P-phrases|261|264|270|271|272|280|301+312|302+352|304+312|304+340|312|321|330|333+313|363|501}} |
|||
⚫ | |||
}} |
}} |
||
'''Cinchonine''' is an [[alkaloid]] |
'''Cinchonine''' is an [[alkaloid]] found in ''[[Cinchona officinalis]]''. It is used in [[asymmetric synthesis]] in organic chemistry. It is a stereoisomer and pseudo-[[enantiomer]] of [[cinchonidine]]. |
||
It is structurally similar to [[quinine]], an [[antimalarial]] drug. |
|||
It is a [[GLP-1 receptor agonist]] and therefore has potential as a possible treatment for obesity, type 2 diabetes, and [[non-alcoholic fatty liver disease]].<ref>{{cite journal |last1=Xue |first1=Huan |last2=Xing |first2=Hao-Jie |last3=Wang |first3=Bin |last4=Fu |first4=Chao |last5=Zhang |first5=Yu-Shan |last6=Qiao |first6=Xi |last7=Guo |first7=Chao |last8=Zhang |first8=Xiao-Li |last9=Hu |first9=Bin |last10=Zhao |first10=Xin |last11=Deng |first11=Li-Jiao |last12=Zhu |first12=Xiao-Chan |last13=Zhang |first13=Yi |last14=Liu |first14=Yun-Feng |title=Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis |journal=Drug Design, Development and Therapy |date=11 May 2023 |volume=17 |pages=1417–1432 |doi=10.2147/DDDT.S404055 |url=https://www.dovepress.com/cinchonine-a-potential-oral-small-molecule-glucagon-like-peptide-1-rec-peer-reviewed-fulltext-article-DDDT |language=English|doi-access=free |pmc=10184894 }}</ref> |
|||
== References == |
|||
<references /> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
[[Category:Quinuclidine alkaloids]] |
|||
[[Category:GLP-1 receptor agonists]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
[[Category:Quinuclidines]] |
|||
[[Category:Alkenes]] |
|||
{{alkaloid-stub}} |
|||
[[ar:سينكونين]] |
|||
[[fr:Cinchonine]] |
|||
[[sv:Cinkonin]] |
Latest revision as of 20:28, 2 January 2024
This article needs additional citations for verification. (January 2021) |
Names | |
---|---|
IUPAC name | |
Systematic IUPAC name
(S)-[(2R,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol | |
Identifiers | |
3D model (JSmol)
|
|
89689 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.003.850 |
EC Number |
|
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H22N2O | |
Molar mass | 294.39 g/mol |
Melting point | 260-263 |
Hazards | |
GHS labelling: | |
Warning | |
H302, H317, H332 | |
P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P321, P330, P333+P313, P363, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Cinchonine is an alkaloid found in Cinchona officinalis. It is used in asymmetric synthesis in organic chemistry. It is a stereoisomer and pseudo-enantiomer of cinchonidine.
It is structurally similar to quinine, an antimalarial drug.
It is a GLP-1 receptor agonist and therefore has potential as a possible treatment for obesity, type 2 diabetes, and non-alcoholic fatty liver disease.[3]
References
[edit]- ^ "Common Chemistry - Substance Details - 118-10-5 : Cinchonan-9-ol, (9S)-". commonchemistry.org. Retrieved 22 May 2020.
- ^ IUPAC Chemical Nomenclature and Structure Representation Division (2013). "P-(Appendix 3, p. 1517)". In Favre, Henri A.; Powell, Warren H. (eds.). Nomenclature of Organic Chemistry: IUPAC Recommendations and Preferred Names 2013. IUPAC–RSC. ISBN 978-0-85404-182-4.
- ^ Xue, Huan; Xing, Hao-Jie; Wang, Bin; Fu, Chao; Zhang, Yu-Shan; Qiao, Xi; Guo, Chao; Zhang, Xiao-Li; Hu, Bin; Zhao, Xin; Deng, Li-Jiao; Zhu, Xiao-Chan; Zhang, Yi; Liu, Yun-Feng (11 May 2023). "Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis". Drug Design, Development and Therapy. 17: 1417–1432. doi:10.2147/DDDT.S404055. PMC 10184894.